Natera
NTRA
#760
Rank
A$46.28 B
Marketcap
A$331.92
Share price
-0.15%
Change (1 day)
17.03%
Change (1 year)

Earnings for Natera (NTRA)

Earnings in 2025 (TTM): -A$0.49 Billion

According to Natera's latest financial reports the company's current earnings are A$2.11 Billion. In 2024 the company made an earning of -A$0.28 Billion, an increase over its 2023 earnings that were of -A$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Natera from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.49 Billion76.44%
2024 -A$0.28 Billion-56.34%
2023 -A$0.63 Billion-20.54%
2022 -A$0.79 Billion16.07%
2021 -A$0.68 Billion105.14%
2020 -A$0.33 Billion86.97%
2019 -A$0.18 Billion-3.92%
2018 -A$0.19 Billion-5.63%
2017 -A$0.2 Billion41.66%
2016 -A$0.14 Billion36.07%
2015 -A$0.11 Billion1264.03%
2014 -A$7.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vertex Pharmaceuticals
VRTX
A$6.40 B-1,539.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Prothena
PRTA
-A$0.32 Billion-28.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
-A$62.77 Million-85.90%๐Ÿ‡บ๐Ÿ‡ธ USA